{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:15:55Z","timestamp":1782310555540,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004828","name":"Grand Challenges Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.xphs.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T11:58:53Z","timestamp":1552478333000},"page":"2805-2813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of Rectodispersible Tablets and Granulate Capsules for the Treatment of Serious Neonatal Sepsis in Developing Countries"],"prefix":"10.1016","volume":"108","author":[{"given":"Tina","family":"Kauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Guyonnet-Dup\u00e9rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thida","family":"Phoeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melba","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2019.03.004_bib1","series-title":"Levels & Trends in Child Mortality: Report 2017, Estimates Developed by the UN Inter-Agency Group for Child Mortality Estimation","year":"2017"},{"key":"10.1016\/j.xphs.2019.03.004_bib2","series-title":"Every Child Alive: The Urgent Need to End Newborn Deaths","year":"2018"},{"issue":"9194","key":"10.1016\/j.xphs.2019.03.004_bib3","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(99)03046-9","article-title":"Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India","volume":"354","author":"Bang","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2019.03.004_bib4","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.jp.7211269","article-title":"Why do neonates die in rural Gadchiroli, India? (Part I): primary causes of death assigned by neonatologist based\u00a0on prospectively observed records","volume":"25","author":"Bang","year":"2005","journal-title":"J\u00a0Perinatol"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2019.03.004_bib5","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1038\/sj.jp.7211270","article-title":"Why do neonates die in rural Gadchiroli, India? (Part II): estimating population attributable risks and contribution of multiple morbidities for identifying a strategy to prevent deaths","volume":"25","author":"Bang","year":"2005","journal-title":"J\u00a0Perinatol"},{"issue":"9979","key":"10.1016\/j.xphs.2019.03.004_bib6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(14)62284-4","article-title":"Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-lab","volume":"385","author":"Tshefu","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.004_bib7","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S2214-109X(16)30335-7","article-title":"Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial","volume":"5","author":"Mir","year":"2017","journal-title":"Lancet Glob Heal"},{"issue":"9628","key":"10.1016\/j.xphs.2019.03.004_bib8","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(08)60835-1","article-title":"Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial","volume":"371","author":"Baqui","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.xphs.2019.03.004_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/INF.0b013e318256f86c","article-title":"Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens","volume":"31","author":"Zaidi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.xphs.2019.03.004_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/jp.2010.191","article-title":"Why do families of sick newborns accept hospital care? A community based cohort study in Karachi, Pakistan","volume":"31","author":"Owais","year":"2012","journal-title":"J\u00a0Perinatol"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2019.03.004_bib11","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/INF.0b013e31829ff801","article-title":"Ensuring quality in AFRINEST and SATT: clinical standardization and monitoring","volume":"32","author":"Wall","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.004_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jps.10563","article-title":"Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of absorption carrier for the ceftriaxone complex","volume":"93","author":"Cho","year":"2004","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.004_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.23.2.191","article-title":"Pharmacokinetics of ceftriaxone in pediatric patients with meningitis","volume":"23","author":"Steele","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2019.03.004_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00441782","article-title":"Pharmacokinetics and safety of ceflriaxone in the neonate","volume":"144","author":"Mulhall","year":"1985","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1016\/j.xphs.2019.03.004_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/clpt.1981.90","article-title":"Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics","volume":"29","author":"Stoeckel","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2019.03.004_bib16","series-title":"Theriaque, French public medical database","year":"2018"},{"key":"10.1016\/j.xphs.2019.03.004_bib17","volume":"Vol 8.1","year":"2018"},{"key":"10.1016\/j.xphs.2019.03.004_bib18","series-title":"Ceftriaxone","year":"2018"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.004_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijantimicag.2013.11.006","article-title":"Dose optimisation of antibiotics in children: application of pharmacokinetics\/pharmacodynamics in paediatrics","volume":"43","author":"Downes","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.xphs.2019.03.004_bib20","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/jps.20478","article-title":"Cationic analog of deoxycholate as an oral delivery carrier for ceftriaxone","volume":"94","author":"Lee","year":"2005","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2019.03.004_bib21","first-page":"1","volume":"109","author":"Dressmann","year":"2005"},{"issue":"12","key":"10.1016\/j.xphs.2019.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01170-18","article-title":"Ceftriaxone absorption enhancement for noninvasive administration as an alternative to injectable solutions","volume":"62","author":"Ba","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2019.03.004_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejps.2017.04.010","article-title":"Preformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulations","volume":"104","author":"Kauss","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.004_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijpharm.2017.11.067","article-title":"Development of rectal self-emulsifying suspension of a moisture-labile water-soluble drug","volume":"536","author":"Kauss","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2019.03.004_bib25","series-title":"The Value of Hard Gelatin Capsules as a Rectal Dosage Form in Man Using Ibuprofen and Metoclopramide Hydrochloride as Model Drugs","author":"Leino","year":"2004"},{"key":"10.1016\/j.xphs.2019.03.004_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1592\/phco.21.2.158.34104","article-title":"Relative bioavailability of lamotrigine chewable dispersible tablets administered rectally","volume":"21","author":"Birnbaum","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.xphs.2019.03.004_bib27","first-page":"1","article-title":"In\u00a0vitro ceftriaxone stability at new-borns \u2019 rectal PH assessed by UV and HPLC methods","volume":"6","author":"Gaudin","year":"2015","journal-title":"Pharm Anal Acta"},{"key":"10.1016\/j.xphs.2019.03.004_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejps.2017.11.006","article-title":"A\u00a0novel double-layer mucoadhesive tablet containing probiotic strain for vaginal administration: design, development and technological evaluation","volume":"112","author":"S\u00e1nchez","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2019.03.004_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/03639045.2017.1386203","article-title":"Mucoadhesive tablets for the vaginal delivery of progesterone: in\u00a0vitro evaluation and pharmacokinetics\/pharmacodynamics in female rabbits","volume":"44","author":"Hassan","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"issue":"27","key":"10.1016\/j.xphs.2019.03.004_bib30","first-page":"19","article-title":"Development of directly compressible mucoadehsive fast disintegrating sublingual tablet system of piroxicam using 3 factor , 3 level box behnken design","volume":"03","author":"Kate","year":"2014","journal-title":"Asian J Biomed Pharm Sci"},{"key":"10.1016\/j.xphs.2019.03.004_bib31","first-page":"1","article-title":"Physicochemical evaluation of mannitol based mucoadhesive fast disintegrating tablet for rapid absorption of piroxicam","volume":"3","author":"Payghan","year":"2013","journal-title":"Inventi Rapid: Pharm Tech"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.004_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/187221109789105658","article-title":"Mucoadhesive vaginal drug delivery systems","volume":"3","author":"Acart\u00fcrk","year":"2009","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1016\/j.xphs.2019.03.004_bib33","first-page":"2249","article-title":"Design and evaluation of mucoadhesive fast disintegrating sublingual tablets containing poorly soluble drug for enhancement of oral bioavailability","volume":"3","author":"Adepu","year":"2013","journal-title":"Am J Pharmatech Res"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.004_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejps.2003.07.002","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance","volume":"20","author":"Bredenberg","year":"2003","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.004_bib35","first-page":"183","article-title":"In-vitro absorption studies of mucoadhesive tablets of acyclovir","volume":"44","author":"Dias","year":"2010","journal-title":"Indian J Pharm Educ Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.03.004_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2005.11.014","article-title":"Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs","volume":"310","author":"Venkatesan","year":"2006","journal-title":"Int J Pharm"},{"issue":"2-3","key":"10.1016\/j.xphs.2019.03.004_bib37","first-page":"107","article-title":"In vitro studies on enhancing effect of sodium glycocholate on transbuccal permeation of\u00a0morphine hydrochloride","volume":"51","author":"Senel","year":"1998","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2019.03.004_bib38","series-title":"Suppositories","author":"Allen","year":"2008"},{"issue":"4","key":"10.1016\/j.xphs.2019.03.004_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/0110-5558.76436","article-title":"Mucoadhesive drug\u00a0delivery system: an overview","volume":"1","author":"Boddupalli","year":"2010","journal-title":"J\u00a0Adv Pharm Technol Res"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.004_bib40","first-page":"81","article-title":"A\u00a0clinical perspective on\u00a0mucoadhesive buccal drug delivery systems","volume":"28","author":"Gilhotra","year":"2014","journal-title":"J\u00a0Biomed Res"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.004_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/md15020050","article-title":"Influence of chitosan swelling behaviour on controlled release of tenofovir from mucoadhesive vaginal systems for prevention of sexual transmission of HIV","volume":"15","author":"Notario-P\u00e9rez","year":"2017","journal-title":"Mar Drugs"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.004_bib42","first-page":"410","article-title":"Comparative study between different ready-made orally disintegrating platforms for the formulation of sumatriptan succinate sublingual tablets","volume":"66","author":"Tayel","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2019.03.004_bib43","volume":"Vol 1","year":"2010"},{"issue":"7","key":"10.1016\/j.xphs.2019.03.004_bib44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/03639040600608888","article-title":"Evaluation and comparison of physicomechanical characteristics of gelatin and hypromellose capsules","volume":"32","author":"Missaghi","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2019.03.004_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919301492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919301492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:25:59Z","timestamp":1758360359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919301492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0022354919301492"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.03.004","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Rectodispersible Tablets and Granulate Capsules for the Treatment of Serious Neonatal Sepsis in Developing Countries","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc. on behalf of the American Pharmacists Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}